Review article · 2022 · Open access
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Cells, 11(8), 1367 · Published 17 April 2022 · DOI 10.3390/cells11081367
In brief
“Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview” is a 2022 review article by Angelica Varesi and 10 co-authors, published in Cells. OpenAlex counts 164 citations as of 19 November 2026, which puts it in the top 4% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Cells.
- Citations
- 164
- Most cited in
- 2025 (52)
- Field-weighted impact
- 3.71
- References
- 422
- Authors
- 11
Abstract
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease characterized by amyloid-β (Aβ) plaque deposition and neurofibrillary tangle accumulation in the brain. Although several studies have been conducted to unravel the complex and interconnected pathophysiology of AD, clinical trial failure rates have been high, and no disease-modifying therapies are presently available. Fluid biomarker discovery for AD is a rapidly expanding field of research aimed at anticipating disease diagnosis and following disease progression over time. Currently, Aβ1–42, phosphorylated tau, and total tau levels in the cerebrospinal fluid are the best-studied fluid biomarkers for AD, but the need for novel, cheap, less-invasive, easily detectable, and more-accessible markers has recently led to the search for new blood-based molecules. However, despite considerable research activity, a comprehensive and up-to-date overview of the main blood-based biomarker candidates is still lacking. In this narrative review, we discuss the role of proteins, lipids, metabolites, oxidative-stress-related molecules, and cytokines as possible disease biomarkers. Furthermore, we highlight the potential of the emerging miRNAs and long non-coding RNAs (lncRNAs) as diagnostic tools, and we briefly present the role of vitamins and gut-microbiome-related molecules as novel candidates for AD detection and monitoring, thus offering new insights into the diagnosis and progression of this devastating disease.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2022). Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview. Cells, 11(8), 1367. https://doi.org/10.3390/cells11081367
MLA 9
Varesi, Angelica, et al. “Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview.” Cells, vol. 11, no. 8, 2022, p. 1367. https://doi.org/10.3390/cells11081367.
Chicago
Varesi, Angelica, Adelaide Carrara, Vitor Gomes Pires, Valentina Floris, Elisa Pierella, Gabriele Savioli, Sakshi Prasad, et al. 2022. “Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview.” Cells 11 (8): 1367. https://doi.org/10.3390/cells11081367.
Harvard
Varesi, A. et al. (2022) ‘Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview’, Cells, 11(8), p. 1367. doi:10.3390/cells11081367.
IEEE
A. Varesi et al., “Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview,” Cells, vol. 11, no. 8, p. 1367, 2022, doi: 10.3390/cells11081367.
BibTeX
@article{varesi2022blood,
title = {{Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview}},
author = {Varesi, Angelica and Carrara, Adelaide and Pires, Vitor Gomes and Floris, Valentina and Pierella, Elisa and Savioli, Gabriele and Prasad, Sakshi and Esposito, Ciro and Ricevuti, Giovanni and Chirumbolo, Salvatore and Pascale, Alessia},
journal = {Cells},
year = {2022},
volume = {11},
number = {8},
pages = {1367},
doi = {10.3390/cells11081367},
url = {https://doi.org/10.3390/cells11081367}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 4 | |
| 2023 | 28 | |
| 2024 | 38 | |
| 2025 | 52 | |
| 2026 | 42 |
Its field-weighted citation impact is 3.71: it has been cited 3.71 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Alzheimer's disease
- blood-based biomarkers
- cerebrospinal fluid biomarkers
- amyloid-beta
- phosphorylated tau
- total tau
- disease progression
- disease diagnosis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., & Pascale, A. (2022). Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview. Cells, 11(8), 1367. https://doi.org/10.3390/cells11081367
How many times has this paper been cited?
164 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cells: sign in and open the PDF from this page.
Who wrote this paper?
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, Valentina Floris, Elisa Pierella, Gabriele Savioli, Sakshi Prasad, Ciro Esposito, Giovanni Ricevuti, Salvatore Chirumbolo, Alessia Pascale.
What is the DOI of this paper?
10.3390/cells11081367, permanently at https://doi.org/10.3390/cells11081367. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.